JD Supra

C.R. Bard v. Atrium: The Impact of FDA Approval Timelines on Royalty Payments

A case pending in the Ninth Circuit Court of Appeals highlights the importance of negotiating the term of royalty payments in the license of Food and Drug Administration (FDA)-regulated products. This ...
JD Supra

C.R. Bard, Inc. Faces First Bellwether Trial Over Hernia Mesh Injuries – Hernia Mesh Lawyer Explains

C.R. Bard, Inc. is one of many medical device companies involved in large nationwide litigation concerning defective hernia mesh products. C.R. Bard, Inc. faces more than 25,000 lawsuits in state and ...
Becker's Hospital Review

FDA Warns of Counterfeit C.R. Bard/Davol Surgical Mesh

U.S. Food and Drug Administration has warned healthcare providers and patients about counterfeit surgical mesh being distributed in the United States under the C.R. Bard/Davol brand name, according to ...
Seeking Alpha

C.R. Bard: A High-Flying Dividend Aristocrat With Strong Growth Prospects

BCR has increased its dividend for over 40 consecutive years. The company's healthcare products are needed regardless of how the economy is doing, resulting in reliable cash flows. Is BCR a buy today ...
Nasdaq

AngioDynamics Settles All Patent Litigation With C.R. Bard

(RTTNews) - AngioDynamics Inc. (ANGO) said that it has reached a settlement agreement with Becton, Dickinson and Company or "BD" to resolve all outstanding patent litigation with C.R. Bard Inc., an ...
Reuters

Jury in Bard mesh trial won't hear about 2011 factory fire, judge rules

Judge finds fire cannot be used to show pattern of conduct Case is third federal bellwether out of more than 19,000 similar claims June 12 (Reuters) - Jurors in an upcoming trial in the case of a man ...
Becker's ASC

Medical supply company pays $17M to settle physician kickback allegations

C.R. Bard and its affiliates — Liberator Medical Supply, Liberator Holdings and Rochester Medical Corporation — agreed to pay $17 million to resolve allegations they provided kickbacks to physician ...
The Pantagraph

Why C.R. Bard Shares Skyrocketed 19.5% Today

Becton, Dickinson will pay C.R. Bard investors $222.93 per share in cash plus 0.5077 shares of BD for each share they own of C.R. Bard. It's an attractive deal for BD because it gives it exposure to ...
MD&M East

Boston Scientific Buys C.R. Bard's Electrophysiology Business

Boston Scientific announced Friday that it is acquiring the electrophysiology business of C.R. Bard for $275 million in cash. The company expects the transaction to close in the second half of the ...
Wall Street Journal

C.R. Bard Acquires Neomend

C.R. Bard Inc., a publicly traded maker of medical, surgical, diagnostic and patient-care devices, said it has agreed to acquire venture-backed Neomend Inc., a maker of sprayable surgical sealants and ...
Reuters

C.R. Bard surgical patch recall is serious: FDA

WASHINGTON (Reuters) - Certain C.R. Bard Inc. surgical patches, already under recall, could cause death or serious health problems, the U.S. Food and Drug Administration said on Thursday. "Customers ...
Seeking Alpha

AngioDynamics settles all patent litigation with C.R. Bard

AngioDynamics (NASDAQ:ANGO) announced that it has entered into a settlement agreement with Becton, Dickinson and Company (NYSE:BDX) to resolve all outstanding patent litigation with C.R. Bard, an ...